Intellia Pauses Phase 3 Crispr Trials After Patient Is Hospitalized
Posted2 months agoActive2 months ago
fiercebiotech.comResearchstory
skepticalnegative
Debate
0/100
CrisprGene EditingClinical Trials
Key topics
Crispr
Gene Editing
Clinical Trials
Intellia has paused its phase 3 CRISPR trials due to a patient hospitalization, raising concerns about the safety and efficacy of the gene editing technology.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
4m
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Oct 27, 2025 at 4:27 PM EDT
2 months ago
Step 01 - 02First comment
Oct 27, 2025 at 4:31 PM EDT
4m after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Oct 27, 2025 at 4:31 PM EDT
2 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45725868Type: storyLast synced: 11/17/2025, 8:05:59 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Road towards the first commercially successful gene therapy continues to be rocky.